Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
JCO Precision Oncology
|
November 9, 2023
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay
Elliot Stieglitz, Christine J Gu, Michelle Richardson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 21, 2022
Inhibition of BTK and PI3Kδ impairs the development of human JMML stem and progenitor cells
Baskar Ramdas, Lisa Deng Yuen, Lakshmi Reddy Palam, et al.
Cancer Discovery
|
June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group
Elliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia
Bogdan Popescu, Matthew F Jones, Madison Piao, et al.
Leukemia
|
September 13, 2019
Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing
Alexander K Chao, Julia A Meyer, Alex G Lee, et al.
Pediatric Blood & Cancer
|
February 24, 2015
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group
Elliot Stieglitz, Ashley F Ward, Robert B Gerbing, et al.
Bone Marrow Transplantation
|
May 12, 2020
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
Vanessa A Fabrizio, Nancy A Kernan, Farid Boulad, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2023
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies
William C Temple, Matthew A Nix, Akul Naik, et al.
Blood Advances
|
September 28, 2021
Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia
Hironobu Kitazawa, Yusuke Okuno, Hideki Muramatsu, et al.
Leukemia
|
September 13, 2018
Downregulating Notch counteracts Kras
Guangyao Kong, Xiaona You, Zhi Wen, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
JCO Precision Oncology
|
November 9, 2023
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay
Elliot Stieglitz, Christine J Gu, Michelle Richardson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 21, 2022
Inhibition of BTK and PI3Kδ impairs the development of human JMML stem and progenitor cells
Baskar Ramdas, Lisa Deng Yuen, Lakshmi Reddy Palam, et al.
Cancer Discovery
|
June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group
Elliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia
Bogdan Popescu, Matthew F Jones, Madison Piao, et al.
Leukemia
|
September 13, 2019
Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing
Alexander K Chao, Julia A Meyer, Alex G Lee, et al.
Pediatric Blood & Cancer
|
February 24, 2015
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group
Elliot Stieglitz, Ashley F Ward, Robert B Gerbing, et al.
Bone Marrow Transplantation
|
May 12, 2020
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
Vanessa A Fabrizio, Nancy A Kernan, Farid Boulad, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2023
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies
William C Temple, Matthew A Nix, Akul Naik, et al.
Blood Advances
|
September 28, 2021
Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia
Hironobu Kitazawa, Yusuke Okuno, Hideki Muramatsu, et al.
Leukemia
|
September 13, 2018
Downregulating Notch counteracts Kras
Guangyao Kong, Xiaona You, Zhi Wen, et al.
Page
of 9